Physician Understanding and Willingness to Prescribe Biosimilars: Findings from a US National Survey

Biosimilar Perceptions Among Healthcare Professionals and Commercial Medical Benefit Policy Analysis in the United States

(2021) Kyle Herndon et al.   BIODRUGS

FDA Biosimilar Action Plan: could improving pharmacovigilance of biologics improve patient and physician confidence in biosimilars?

(2020) John B Jordan et al.   Expert Opinion On Drug Safety

Coverage for Biosimilars vs Reference Products Among US Commercial Health Plans

(2020) James D. Chambers et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Physicians’ perceptions of the uptake of biosimilars: a systematic review

(2020) Kati Sarnola et al.   BMJ Open

Biosimilar Uptake in Academic and Veterans Health Administration Settings: Influence of Institutional Incentives

(2020) Joshua F. Baker et al.   Arthritis & Rheumatology

The Importance of Countering Biosimilar Disparagement and Misinformation

(2020) Hillel P. Cohen et al.   BIODRUGS

The biosimilar pathway in the USA: An analysis of the innovator company and biosimilar company perspectives and beyond

(2019) Lin-Chau Chang   JOURNAL OF FOOD AND DRUG ANALYSIS

Biosimilar Filgrastim Uptake And Costs Among Commercially Insured, Medicare Advantage

(2019) Pinar Karaca-Mandic et al.   HEALTH AFFAIRS

Uptake of the Biologic Filgrastim and Its Biosimilar Product Among the Medicare Population

(2018) Steven Kozlowski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Out-of-Pocket Costs for Infliximab and Its Biosimilar for Rheumatoid Arthritis Under Medicare Part D

(2018) Jinoos Yazdany et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The US Biosimilar Market: Stunted Growth and Possible Reforms

(2018) Ameet Sarpatwari et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland

(2017) Joan O'Callaghan et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Knowledge, attitude and practice of healthcare professionals towards infliximab and insulin glargine biosimilars: result of a UK web-based survey

(2017) Stephen R Chapman et al.   BMJ Open

Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians

(2016) Hillel Cohen et al.   ADVANCES IN THERAPY